Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN vs NAPROXEN\SUMATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN vs NAPROXEN\SUMATRIPTAN: Safety Overview

Metric NAPROXEN NAPROXEN\SUMATRIPTAN
Total FAERS Reports 52,751 233
Deaths Reported 5,127 15
Death Rate 9.7% 6.4%
Hospitalizations 12,849 14
Average Patient Age 55.0 yrs 47.8 yrs
% Female Patients 71.5% 84.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Aurobindo Pharma Limited N/A
Route ORAL N/A
Marketing Status Discontinued N/A